Cervical ripening /Labour induction in postdate nulliparas; Comparative study of vaginal misoprostol versus vaginal misoprostol with rectal hyoscine-butylbromide

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407560838827

Enrollment

Registered

2024-07-29

Start date

2024-08-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postdate pregnancy

Interventions

Vaginal misoprostol with hyoscine butyl bromide

Vaginal Misoprostol with hyoscine Butylbromide

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Those who will give consent to the study. 2. Nulliparous pregnant women. 3. Postdate pregnancy. 4. Selected for cervical ripening and induction of labour. 5 Singleton pregnancy with vertex presentation.

Exclusion criteria

Exclusion criteria: 1. maternal co-morbidities like hypertension, diabetes Mellitus, 2. Pregnancy complications like antepartum haemorrhage and severe pre-eclampsia Those allergic to hyoscine Those contraindicated to receive prostaglandins like asthma and glaucoma 5. Previous caesarian scar 6. Contraindication to vaginal delivery Malpresentation

Design outcomes

Primary

Measure	Time frame
Cervical ripening as determined by changes in the Bishops score following insertion	—

Secondary

Measure	Time frame
Induction-delivery interval. Successful vaginal delivery or caesarian section rate. Need for supplemental oxytocin augmentation	—

Countries

Nigeria

Contacts

Public ContactAuhustus Otogwung

Senior Registrar Obstetrics and Gynaecology Rivers State University Hospital

augom70@yahoo.com+2348034679390

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026